Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (18573)	2/8/1999 12:45:00 AM
From: BigKNY3	Read Replies (1) \| Respond to of 23519

OT V-Man <<Based on this reason alone, I think there are too many value plays out there for funds to keep pouring money into these stock in the near future. Look at your favorite Pfizer. The Viagra hype gave it a run up to about 130 last spring and here we are 10 months later at about the same price.>> V-Man: The trick is to buy quality stocks when they are significantly off their highs. That's why GLX (17% off its high)is a better short-term Pharma value on Monday than PFE (only 4% off its high). BigKNY3 PS For the record PFE is currently 8% higher than its Spring 1998 high of 121.75 (4/21/98) and 52% higher than its October 1998 low. Accordingly, there were excellent buying opportunities during the profit-taking valleys following the normal peaks of Pharma prices.